1 results match your criteria: "Clinical Research Building B 416[Affiliation]"
Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis.
Cardiooncology
November 2024
Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Clinical Research Building B 416, Higashi-Ku, Fukuoka, 812-8582, Japan.
The advent of immune checkpoint inhibitors (ICIs) has significantly improved cancer treatment. With the increasing use of ICIs, ICI-related myocarditis has been recognized. However, an evidence-based therapeutic strategy has not been established because of the limited knowledge on ICI-related myocarditis.
View Article and Find Full Text PDF